Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
312.5 USD | -0.71% | +0.75% | +8.49% |
17/05 | US FDA approves Amgen drug for small cell lung cancer | RE |
16/05 | Amgen Gets FDA Approval for Small-Cell Lung-Cancer Treatment | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.49% | 17TCr | |
+32.09% | 69TCr | |
+29.39% | 59TCr | |
-1.34% | 37TCr | |
+20.34% | 33TCr | |
+7.39% | 29TCr | |
+14.25% | 24TCr | |
-3.03% | 21TCr | |
+10.02% | 21TCr | |
-0.52% | 16TCr |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- Deutsche Bank Adjusts Price Target on Amgen to $310 From $285, Hold Rating Maintained